SOTTOTETTI, FEDERICO
 Distribuzione geografica
Continente #
NA - Nord America 656
EU - Europa 416
AS - Asia 132
SA - Sud America 6
AF - Africa 1
Totale 1.211
Nazione #
US - Stati Uniti d'America 655
IE - Irlanda 193
CN - Cina 93
FI - Finlandia 60
IT - Italia 53
DE - Germania 43
UA - Ucraina 31
SE - Svezia 19
SG - Singapore 19
JP - Giappone 16
FR - Francia 4
GB - Regno Unito 4
BE - Belgio 3
BR - Brasile 3
IN - India 3
RU - Federazione Russa 2
AR - Argentina 1
AT - Austria 1
CA - Canada 1
CL - Cile 1
CZ - Repubblica Ceca 1
IM - Isola di Man 1
LT - Lituania 1
MU - Mauritius 1
PE - Perù 1
TR - Turchia 1
Totale 1.211
Città #
Dublin 193
Chandler 180
Helsinki 48
Ashburn 47
Boardman 42
New York 38
Jacksonville 34
Princeton 30
Lawrence 27
Nanjing 27
Medford 23
Shanghai 22
Wilmington 15
Milan 14
Tokyo 14
Pavia 10
Nanchang 9
Los Angeles 8
Singapore 8
Beijing 7
Dallas 7
Hebei 7
Norwalk 7
Shenyang 6
Changsha 5
Chicago 4
Verona 4
Brussels 3
Cinisello Balsamo 3
Falls Church 3
Hangzhou 3
Mariglianella 3
Pune 3
Seattle 3
Washington 3
Woodbridge 3
Ann Arbor 2
Bergamo 2
Berlin 2
Falkenstein 2
Jiaxing 2
Kazan 2
Munich 2
Naples 2
Osaka 2
Rockville 2
San Francisco 2
Tappahannock 2
Tianjin 2
Verdello 2
West Jordan 2
Brno 1
Buenos Aires 1
Catalao 1
Changchun 1
Douglas 1
Edmonton 1
Fairfield 1
Forest City 1
Fuzhou 1
Galatro 1
Gunzenhausen 1
Kunming 1
Lima 1
London 1
Misterbianco 1
Modena 1
Montereale Valcellina 1
Redmond 1
Redwood City 1
Rozzano 1
Santiago Metropolitan 1
São Paulo 1
Tremestieri Etneo 1
Urbino 1
Totale 917
Nome #
Complications of image-guided transcatheter hepatic chemoembolization of primary and secondary tumours of the liver. 70
OEM-TACE: a new therapeutic approach in unresectable intrahepatic cholangiocarcinoma. 69
Transhepatic arterial chemoembolization with oxaliplatin-eluting microspheres (OEM-TACE) for Unresectable Hepatic Tumors. 59
Intravenous or oral vinorelbine plus capecitabine as first - line treatment in HER2- metastatic breast cancer: Joint Analysis of 2 Consecutive Prospective Phase II Trials. 55
Uncommon dihydropyrimidine dehydrogenase mutations and toxicity by fluoropyrimidines: A lethal case with a new variant 52
Intravenous or oral vinorelbine plus capecitabine as first-line treatment in HER2- metastatic breast cancer: joint analysis of 2 consecutive prospective phase II trials. 50
Prognostic Value of 18 F-Fluorocholine PET Parameters in Metastatic Castrate-Resistant Prostate Cancer Patients Treated with Docetaxel 45
Patterns of treatment and outcome of palbociclib plus endocrine therapy in hormone receptor-positive/HER2 receptor-negative metastatic breast cancer: a real-world multicentre Italian study 45
Eribulin across multiple lines of chemotherapy: A retrospective study on quality of life and efficacy in metastatic breast cancer patients 45
Palbociclib in metastatic breast cancer: Current evidence and real-life data 42
Treatment of chronic hepatitis C in a patient affected by systemic sclerosis 42
Clinical outcomes of patients with breast cancer relapsing after (neo)adjuvant trastuzumab and receiving trastuzumab rechallenge or lapatinib-based therapy: a multicentre retrospective cohort study 41
Role of androgen receptor expression in early stage ER+/PgR−/HER2– breast cancer 41
Which patients with metastatic breast cancer benefit from subsequent lines of treatment? An update for clinicians 40
Cluster familiare di mesotelioma da esposizione residenziale 38
Raman analysis of microcalcifications in male breast cancer 36
Acute thrombocytopenia: An unusual complication occurring after drug-eluting microspheres transcatheter hepatic chemoembolization 35
Nanoparticle albumin-bound paclitaxel (Nab-paclitaxel) as second-line chemotherapy in HER2-negative, taxane-pretreated metastatic breast cancer patients: Prospective evaluation of activity, safety, and quality of life 35
Italian real life experience with ibrutinib: Results of a large observational study on 77 relapsed/refractory mantle cell lymphoma 35
Patterns of Care and Clinical Outcomes of HER2-positive Metastatic Breast Cancer Patients With Newly Diagnosed Stage IV or Recurrent Disease Undergoing First-line Trastuzumab-based Therapy: A Multicenter Retrospective Cohort Study 35
Vinflunine in Advanced Transitional Cell Cancer of the Urothelial Tract: A Potential Option for Maintenance Therapy? A Case Series 34
Impact of COVID-19 outbreak on cancer patient care and treatment: Data from an outpatient oncology clinic in Lombardy (Italy) 33
Targeted chemotherapy with nanoparticle albumin-bound paclitaxel (nab -paclitaxel) in metastatic breast cancer: Which benefit for which patients? 32
Advanced salivary gland carcinoma expressing androgen receptor and HER2: targeted therapies first? 32
Impact of body mass index on the clinical outcomes of patients with HER2-positive metastatic breast cancer 32
Feasibility and safety of extended pleurectomy/decortication for malignant pleural mesothelioma. A single group experience 30
Validation of an LC-MS/MS method for the determination of epirubicin in human serum of patients undergoing Drug Eluting Microsphere-Transarterial Chemoembolization (DEM-TACE) 30
Patterns of treatment and outcome with 500-mg fulvestrant in postmenopausal women with hormone receptor-positive/HER2-negative metastatic breast cancer: a real-life multicenter Italian experience 30
Clinical and Biological Variables Influencing Outcome in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) Treated with Anti-PD-1/PD-L1 Antibodies: A Prospective Multicentre Study 23
Mental health and risk perception among Italian healthcare workers during the second month of the Covid-19 pandemic 21
Small bowel villous atrophy due to immune-checkpoint inhibitors: report of two cases and literature review 19
Smoking Habit and Respiratory Function Predict Patients' Outcome after Surgery for Lung Cancer, Irrespective of Histotype and Disease Stage 17
Tackling the clinical complexity of breast cancer 9
Totale 1.252
Categoria #
all - tutte 6.894
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.894


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202029 0 0 0 6 0 6 3 6 1 6 1 0
2020/202154 9 6 1 6 1 7 0 6 3 7 7 1
2021/2022160 0 0 34 2 2 1 1 4 11 13 16 76
2022/2023517 66 60 5 35 36 42 1 24 224 1 11 12
2023/2024290 41 48 9 9 21 80 19 16 0 15 9 23
2024/2025101 21 43 36 1 0 0 0 0 0 0 0 0
Totale 1.252